Vincristine pharmacokinetics pathway and neurotoxicity during early phases of treatment in pediatric acute lymphoblastic leukemia

被引：57

作者：

Lopez-Lopez, Elixabet ^{[1
]}

Gutierrez-Camino, Angela ^{[1
]}

Astigarraga, Itziar ^{[2
]}

Navajas, Aurora ^{[2
]}

Echebarria-Barona, Aizpea ^{[2
]}

Garcia-Miguel, Purificacion ^{[3
]}

Garcia de Andoin, Nagore ^{[4
]}

Lobo, Carmen ^{[5
]}

Guerra-Merino, Isabel ^{[6
]}

Martin-Guerrero, Idoia ^{[1
]}

Garcia-Orad, Africa ^{[1
,7
]}

机构：

[1] Univ Basque Country UPV EHU, Fac Med & Odontol, Dept Genet Phys Anthropol & Anim Physiol, Leioa, Spain

[2] Univ Hosp Cruces, Pediat Hematol Oncol Unit, Bilbao, Spain

[3] Univ Hosp La Paz, Serv Pediat Oncohematol, Madrid, Spain

[4] Univ Hosp Donostia, Unit Pediat Oncohematol, San Sebastian, Spain

[5] Univ Hosp Donostia, Dept Anat Pathol, Donostia San Sebastian, Spain

[6] Univ Hosp Araba, Dept Pathol, Araba, Spain

[7] BioCruces Hlth Res Inst, Baracaldo, Spain

来源：

PHARMACOGENOMICS | 2016年 / 17卷 / 07期

关键词：

acute lymphoblastic leukemia; neurotoxicity; pharmacokinetics; polymorphism; vincristine; MULTIDRUG-RESISTANCE; PERIPHERAL NEUROPATHY; DRUG-RESISTANCE; POLYMORPHISMS; CHILDREN; GENE; PHARMACODYNAMICS; ASSOCIATION; POPULATION; DATABASE;

D O I：

10.2217/pgs-2016-0001

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

Aim: Vincristine is an important component of acute lymphoblastic leukemia (ALL) treatment protocols that can cause neurotoxicity. Patients treated with LAL/SHOP protocols often suffer from vincristine-related neurotoxicity in early phases of treatment. Recently, a genome-wide association study connected a SNP in CEP72, involved in vincristine pharmacodynamics, with neurotoxicity during later phases of therapy, which was not replicated during induction phase. These results, together with previous studies indicating that polymorphisms in pharmacokinetic genes are associated with drug toxicity, suggest that changes in the activity or levels of vincristine transporters or metabolizers could work as predictors of vincristine-related neurotoxicity in early phases of treatment in pediatric ALL. Patients & methods: We analyzed 150 SNPs in eight key genes involved in vincristine pharmacokinetics and in 13 miRNAs that regulate them. We studied their correlation with neurotoxicity during induction phase in 152 ALL patients treated with LAL/SHOP protocols. Results: The strongest associations with neurotoxicity were observed for two SNPs in ABCC2. The genotypes rs3740066 GG and rs12826 GG were associated with increased neurotoxicity. Conclusion: Polymorphisms in ABCC2 could be novel markers for vincristine-related neurotoxicity in pediatric ALL in early phases.

引用

页码：731 / 741

页数：11

共 30 条

[1] CONTROLLING THE FALSE DISCOVERY RATE - A PRACTICAL AND POWERFUL APPROACH TO MULTIPLE TESTING [J].

BENJAMINI, Y ;

HOCHBERG, Y .

JOURNAL OF THE ROYAL STATISTICAL SOCIETY SERIES B-STATISTICAL METHODOLOGY, 1995, 57 (01) :289-300

[2] Chemotherapy-induced peripheral neuropathy: What do we know about mechanisms? [J].

Carozzi, V. A. ;

Canta, A. ;

Chiorazzi, A. .

NEUROSCIENCE LETTERS, 2015, 596 :90-107

[3]

Ceppi F, 2014, PHARMACOGENOMICS, V15, P1105, DOI [10.2217/PGS.14.68, 10.2217/pgs.14.68]

[4]

Cui YH, 1999, MOL PHARMACOL, V55, P929

[5] Selective metabolism of vincristine in vitro by CYP3A5 [J].

Dennison, Jennifer B. ;

Kulanthaivel, Palaniappan ;

Barbuch, Robert J. ;

Renbarger, Jamie L. ;

Ehlhardt, William J. ;

Hall, Stephen D. .

DRUG METABOLISM AND DISPOSITION, 2006, 34 (08) :1317-1327

[6] Association of an Inherited Genetic Variant With Vincristine-Related Peripheral Neuropathy in Children With Acute Lymphoblastic Leukemia [J].

Diouf, Barthelemy ;

Crews, Kristine R. ;

Lew, Glen ;

Pei, Deqing ;

Cheng, Cheng ;

Bao, Ju ;

Zheng, Jie J. ;

Yang, Wenjian ;

Fan, Yiping ;

Wheeler, Heather E. ;

Wing, Claudia ;

Delaney, Shannon M. ;

Komatsu, Masaaki ;

Paugh, Steven W. ;

McCorkle, Joseph Robert ;

Lu, Xiaomin ;

Winick, Naomi J. ;

Carroll, William L. ;

Loh, Mignon L. ;

Hunger, Stephen P. ;

Devidas, Meenakshi ;

Pui, Ching-Hon ;

Dolan, M. Eileen ;

Relling, Mary V. ;

Evans, William E. .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2015, 313 (08) :815-823

[7]

Drake KJ, 2007, INT J ONCOL, V30, P139

[8] Increased Risk of Vincristine Neurotoxicity Associated With Low CYP3A5 Expression Genotype in Children With Acute Lymphoblastic Leukemia [J].

Egbelakin, Akinbode ;

Ferguson, Michael J. ;

MacGill, Emily A. ;

Lehmann, Amalia S. ;

Topletz, Ariel R. ;

Quinney, Sara K. ;

Li, Lang ;

McCammack, Kevin C. ;

Hall, Stephen D. ;

Renbarger, Jamie L. .

PEDIATRIC BLOOD & CANCER, 2011, 56 (03) :361-367

[9] Reversal of drug resistance of hepatocellular carcinoma cells by adenoviral delivery of anti-ABCC2 antisense constructs [J].

Folmer, Y. ;

Schneider, M. ;

Blum, H. E. ;

Hafkemeyer, P. .

CANCER GENE THERAPY, 2007, 14 (11) :875-884

[10] The structure of haplotype blocks in the human genome [J].

Gabriel, SB ;

Schaffner, SF ;

Nguyen, H ;

Moore, JM ;

Roy, J ;

Blumenstiel, B ;

Higgins, J ;

DeFelice, M ;

Lochner, A ;

Faggart, M ;

Liu-Cordero, SN ;

Rotimi, C ;

Adeyemo, A ;

Cooper, R ;

Ward, R ;

Lander, ES ;

Daly, MJ ;

Altshuler, D .

SCIENCE, 2002, 296 (5576) :2225-2229

← 1 2 3 →